This is in line with work by Sakai et al (as well as by Morakata et al) in the allergic asthma model, who reported suppressed IFN-g levels to in vitro recall stimulation of splenocytes from hi-dose (1000 μg OVA) allergen sensitized mice [10,11]. The gene discussed is IFNG; the disease is allergic asthma.